recombinant human parathyroid hormone for injection (1-34)
注射用重组人甲状旁腺素（1-34）
Report date: 2025/01/07 14:46:58
Base Information
Drug Namerecombinant human parathyroid hormone for injection (1-34)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesNanjing Suji Biomedical Research And Development Co LtdJiangsu High-Tech Entrepreneurship Service Center
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesJiangsu High-Tech Entrepreneurship Service CenterNanjing Suji Biomedical Research And Development Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A